Myriad Genetics, Inc. – Trademark Portfolio

Entity Type: 03

Myriad Genetics, Inc. holds 107 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 60 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 9 Nice Classification classes. Currently, 36 trademarks are registered and 6 are pending. Notable registered marks include CPGX, M-CO, PHENO, MYPATH, and MYRIAD. The owner is based in Salt Lake City, UT.